Orchestra Biomed Holdings Inc
OBIO3.810USD
-0.110-2.81%
收盘 11/06, 16:00（美东）报价延迟15分钟
147.23M总市值
亏损市盈率 TTM
关于 Orchestra Biomed Holdings Inc 公司
Orchestra BioMed Holdings, Inc. 是一家生物医学创新公司。其主要候选产品是 BackBeat 心脏神经调节疗法 (BackBeat CNT)，用于治疗高血压 (HTN)，高血压是全球最大的死亡风险因素。该公司还在开发 Virtue Sirolimus 血管输注球囊 (Virtue SAB)，用于治疗动脉粥样硬化性动脉疾病，动脉粥样硬化性动脉疾病是全球最大的死亡原因。该公司正在开发基于专利 CNT 技术的生物电子疗法。BackBeat CNT，也称为房室间隔调节 (AVIM) 疗法，是一种生物电子疗法候选产品，旨在大幅持续降低血压。Virtue SAB 是一种专有的药物/设备组合候选产品，用于治疗动脉疾病，旨在在球囊血管成形术期间向血管壁输送专有的、研究性的、缓释的雷帕霉素 (SirolimusEFR) 制剂，无需球囊涂层或永久植入。
Orchestra Biomed Holdings Inc简介
公司代码OBIO
公司名称Orchestra Biomed Holdings Inc
上市日期Aug 04, 2020
CEOMr. David P. Hochman
员工数量70
证券类型Ordinary Share
年结日Aug 04
公司地址150 Union Square Drive
城市NEW HOPE
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编18938
电话16463439298
网址
公司代码OBIO
上市日期Aug 04, 2020
CEOMr. David P. Hochman
Orchestra Biomed Holdings Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. David P. Hochman
Mr. David P. Hochman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
475.85K
-7.82%
Mr. Andrew Lawrence Taylor
Mr. Andrew Lawrence Taylor
Chief Financial Officer
Chief Financial Officer
163.97K
-8.94%
Dr. Eric S. Fain, M.D.
Dr. Eric S. Fain, M.D.
Lead Independent Director
Lead Independent Director
54.31K
+16.02%
Ms. Pamela Ann Connealy
Ms. Pamela Ann Connealy
Independent Director
Independent Director
48.71K
+44.50%
Mr. David Pacitti
Mr. David Pacitti
Independent Director
Independent Director
37.46K
+66.77%
Mr. John Mack
Mr. John Mack
Independent Director
Independent Director
33.42K
+81.41%
Mr. Darren R. Sherman
Mr. Darren R. Sherman
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
--
--
Mr. Christopher (Chris) Cleary
Mr. Christopher (Chris) Cleary
Independent Director
Independent Director
--
--
Mr. Jason Aryeh
Mr. Jason Aryeh
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. David P. Hochman
Mr. David P. Hochman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
475.85K
-7.82%
Mr. Andrew Lawrence Taylor
Mr. Andrew Lawrence Taylor
Chief Financial Officer
Chief Financial Officer
163.97K
-8.94%
Dr. Eric S. Fain, M.D.
Dr. Eric S. Fain, M.D.
Lead Independent Director
Lead Independent Director
54.31K
+16.02%
Ms. Pamela Ann Connealy
Ms. Pamela Ann Connealy
Independent Director
Independent Director
48.71K
+44.50%
Mr. David Pacitti
Mr. David Pacitti
Independent Director
Independent Director
37.46K
+66.77%
Mr. John Mack
Mr. John Mack
Independent Director
Independent Director
33.42K
+81.41%
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 10月30日 周四
更新时间: 10月30日 周四
持股股东
股东类型
持股股东
持股股东
占比
RTW Investments L.P.
15.39%
Medtronic PLC
10.88%
Perceptive Advisors LLC
9.81%
The Vanguard Group, Inc.
2.15%
HSAC 2 Holdings LLC
1.77%
其他
60.00%
持股股东
持股股东
占比
RTW Investments L.P.
15.39%
Medtronic PLC
10.88%
Perceptive Advisors LLC
9.81%
The Vanguard Group, Inc.
2.15%
HSAC 2 Holdings LLC
1.77%
其他
60.00%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
17.51%
Corporation
12.65%
Private Equity
9.81%
Investment Advisor
4.70%
Individual Investor
3.42%
Hedge Fund
2.69%
Research Firm
0.28%
Family Office
0.16%
Venture Capital
0.03%
其他
48.75%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
130
18.90M
35.03%
-567.38K
2025Q2
131
26.96M
59.74%
-4.30M
2025Q1
136
28.97M
75.74%
-4.21M
2024Q4
145
29.39M
77.32%
-6.48M
2024Q3
139
29.24M
78.21%
-5.77M
2024Q2
173
27.85M
75.29%
-10.18M
2024Q1
173
26.52M
74.14%
-11.97M
2023Q4
170
26.50M
74.14%
-13.80M
2023Q3
165
26.04M
76.97%
-3.70M
2023Q2
163
22.38M
66.83%
-7.49M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
RTW Investments L.P.
8.31M
15.39%
+1.00
+0.00%
Aug 04, 2025
Medtronic PLC
5.87M
10.88%
--
--
Apr 28, 2025
Perceptive Advisors LLC
5.29M
9.81%
+700.00K
+15.24%
Aug 01, 2025
The Vanguard Group, Inc.
1.16M
2.15%
-150.45K
-11.50%
Jun 30, 2025
HSAC 2 Holdings LLC
955.71K
1.77%
-3.41M
-78.08%
Aug 05, 2024
Hochman (David P)
475.85K
0.88%
-40.35K
-7.82%
Sep 17, 2025
Knoll Capital Management, LLC
455.13K
0.84%
+455.13K
--
Jun 30, 2025
T. Rowe Price Associates, Inc.
430.82K
0.8%
-10.02K
-2.27%
Jun 30, 2025
Millennium Management LLC
409.67K
0.76%
+409.67K
--
Jun 30, 2025
BlackRock Financial Management, Inc.
404.71K
0.75%
-155.40K
-27.74%
Jun 30, 2025
查看更多
持股ETF
更新时间: 18 小时前
更新时间: 18 小时前
机构名称
占比
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Value ETF
0%
Avantis US Small Cap Equity ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 Growth ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Schwab U.S. Small-Cap ETF
0%
查看更多
iShares Micro-Cap ETF
占比0.01%
iShares Russell 2000 ETF
占比0%
iShares Russell 2000 Value ETF
占比0%
Avantis US Small Cap Equity ETF
占比0%
ProShares UltraPro Russell2000
占比0%
iShares Russell 2000 Growth ETF
占比0%
DFA Dimensional US Sustainability Core 1 ETF
占比0%
ProShares Hedge Replication ETF
占比0%
Global X Russell 2000 ETF
占比0%
Schwab U.S. Small-Cap ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
